Finance

Lists
600833:SHA
Shanghai No.1 Pharmacy Co Ltd
CNÂ¥10.56
+1.64%
(+0.17) 1D
Oct 9, 3:00:00 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600833...
Open
CNÂ¥10.39
High
CNÂ¥10.60
Low
CNÂ¥10.23
Mkt. cap
2.32B
Avg. vol.
6.25M
Volume
4.95M
Dividend
0.74%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 26, 2026
P/E ratio
33.71
52-wk high
CNÂ¥15.55
52-wk low
CNÂ¥8.83
EPS
CNÂ¥0.31
Shares outstanding
223.09M
No. of employees
818
Open
CNÂ¥10.39
High
CNÂ¥10.60
Low
CNÂ¥10.23
Mkt. cap
2.32B
Avg. vol.
6.25M
Volume
4.95M
Dividend
0.74%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 26, 2026
P/E ratio
33.71
52-wk high
CNÂ¥15.55
52-wk low
CNÂ¥8.83
EPS
CNÂ¥0.31
Shares outstanding
223.09M
No. of employees
818
News stories
From web sources and news partners
About Shanghai No.1 Pharmacy Co Ltd
CEO-
Employees818
FoundedSep 23, 1992
Headquarters-
SectorDrug
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
542.48M
591.16M
484.56M
497.01M
Cost of goods sold
456.34M
501.71M
413.36M
418.65M
Cost of revenue
456.34M
501.71M
413.36M
418.65M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
85.76M
89.74M
72.40M
81.79M
Operating expense
86.94M
93.69M
72.76M
84.41M
Total operating expenses
543.28M
595.40M
486.12M
503.06M
Operating income
-795.06K
-4.25M
-1.56M
-6.05M
Other non operating income
-841.60K
232.61K
-117.44K
-82.80K
EBT including unusual items
52.37M
5.93M
30.96M
3.05M
EBT excluding unusual items
1.25M
-1.22M
1.45M
761.28K
Income tax expense
12.68M
1.41M
7.30M
214.41K
Effective tax rate
24.20%
23.82%
23.57%
7.04%
Other operating expenses
1.28M
2.02M
994.91K
1.28M
Net income
39.25M
4.48M
23.26M
2.91M
Net profit margin
7.23%
0.76%
4.80%
0.58%
Earnings per share
-
-
-
-
Interest and investment income
4.07M
5.41M
3.95M
7.63M
Interest expense
-1.11M
-1.02M
-815.89K
-668.37K
Net interest expenses
2.96M
4.39M
3.13M
6.96M
Depreciation and amortization charges
-
-
-
-
EBITDA
819.56K
-2.43M
252.64K
-4.23M
Gain or loss from assets sale
404.94K
-50.18M
-
-30.73M
AI content may include mistakes. Learn more
Google apps